Multi-omics data integration-gene expression

This heatmap represents gene expression profiling with hierarchical clustering analysis between two molecular subtypes, CMS1 and CMS3. In this analysis, rows represent genes while columns represent biological samples. The colour scale indicates relative gene expression levels, where red corresponds to high expression, blue indicates low expression, and intermediate colours represent moderate expression levels. The dendrograms generated through hierarchical clustering group both genes and samples according to similarity in their expression patterns. This heatmap demonstrates that CMS1 and CMS3 possess partially distinct gene expression signatures, indicating molecular heterogeneity between the subtypes. Certain clusters of genes show subtype-specific upregulation or downregulation, suggesting differences in biological pathways and cellular mechanisms. Although some overlap exists between the groups, the clustering pattern supports the classification of these samples into biologically meaningful molecular subtypes. This type of gene expression analysis is highly significant in modern biomedical and cancer research because it helps identify biomarkers, understand disease mechanisms, and classify patients based on molecular characteristics. The findings may contribute to precision medicine approaches by enabling subtype-specific diagnosis and treatment strategies. For example, subtype-associated genes may serve as therapeutic targets or predictors of treatment response. Future perspectives of this include the integration of artificial intelligence, machine learning, and multi-omics technologies to improve disease classification and personalized therapy. Advances such as single-cell sequencing and spatial transcriptomics may further enhance understanding of tumor heterogeneity and molecular interactions. Ultimately, gene expression profiling is expected to become an important clinical tool for improving diagnosis, prognosis, and individualized treatment planning in precision oncology.